Motagon is the cannabis subsidiary of international Czech
pharmaceutical company, Heaton AS, and a joint venture with
Jelinda (Germany) and KOMAND Consulting (Canada).
Our mission is to guarantee that the optimal
cannabis-based medicine is made available to
all patients that can benefit from the qualities
of the cannabis plant.
Motagon accesses Heaton’s global sales
and distribution network.
We source and contract manufacture effective cannabis-based pharmaceuticals from around the globe, including Spain, Portugal,and Canada.
LICENSES AND CERTIFICATIONS
EU manufactured cannabis flowers in following concentrations
EU manufactured full-spectrum extracts
Advanced product forms
Expertise from leading global markets
We use our proprietary artificial intelligence technologies to process large amounts of real world data and help physicians make informed decisions that best serve their patients and improve health outcomes.
Jaromir Fric jr.
Director, Corporate Development
Head of QA, QP
Regulatory Affairs Manager
Head of Logistics
Motagon becomes the first Czech company to establish medical cannabis supply from Australia/New Zealand
August 1, 2022, Prague – Motagon has announced today that it has entered into an exclusive five-year cooperation with New Zealand-based Rua...
(Určeno pouze pro návštěvníky webu z České republiky) Společnost Motagon Vás zve na round table meeting s uživateli léčebné konopí. Jaké jsou...
Motagon Cannabis, a subsidiary of international pharma company HEATON Group a.s., brings GG4 (Gorilla Glue 4), a high-THC medical cannabis flower,...